勘误：一种新型噬菌体PD-6A3及其溶菌酶Ply6A3，具有针对……的扩展裂解活性
Corrigendum: A Novel Phage PD-6A3, and Its Endolysin Ply6A3, With Extended Lytic Activity Against .
作者信息
Wu Minle, Hu Kongying, Xie Youhua, Liu Yili, Mu Di, Guo Huimin, Zhang Zhifan, Zhang Yingcong, Chang Dong, Shi Yi
机构信息
Department of Clinical Laboratory, Shanghai Pudong Hospital, Fudan University, Shanghai, China.
Key Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
出版信息
Front Microbiol. 2019 Feb 12;10:196. doi: 10.3389/fmicb.2019.00196. eCollection 2019.
Abstract
[This corrects the article DOI: 10.3389/fmicb.2018.03302.].
摘要
[本文更正了文章的数字对象标识符：10.3389/fmicb.2018.03302。]
相似文献
1
Corrigendum: A Novel Phage PD-6A3, and Its Endolysin Ply6A3, With Extended Lytic Activity Against .勘误：一种新型噬菌体PD-6A3及其溶菌酶Ply6A3，具有针对……的扩展裂解活性
Front Microbiol. 2019 Feb 12;10:196. doi: 10.3389/fmicb.2019.00196. eCollection 2019.
2
A Novel Phage PD-6A3, and Its Endolysin Ply6A3, With Extended Lytic Activity Against .一种新型噬菌体PD-6A3及其溶菌酶Ply6A3，具有针对……的扩展裂解活性
Front Microbiol. 2019 Jan 9;9:3302. doi: 10.3389/fmicb.2018.03302. eCollection 2018.
3
Antibacterial properties of Acinetobacter baumannii phage Abp1 endolysin (PlyAB1).鲍曼不动杆菌噬菌体Abp1溶菌酶（PlyAB1）的抗菌特性
BMC Infect Dis. 2014 Dec 12;14:681. doi: 10.1186/s12879-014-0681-2.
4
Corrigendum: Isolation and Characterization of a Novel Myophage Abp9 Against Pandrug Resistant .勘误：一种针对泛耐药菌的新型肌尾噬菌体Abp9的分离与鉴定
Front Microbiol. 2020 Dec 3;11:625283. doi: 10.3389/fmicb.2020.625283. eCollection 2020.
5
Corrigendum: Characterization of Two Novel Bacteriophages Infecting Multidrug-Resistant (MDR) and Evaluation of Their Therapeutic Efficacy .勘误：两种感染多重耐药菌（MDR）的新型噬菌体的特性及其治疗效果评估
Front Microbiol. 2022 Jan 5;12:815173. doi: 10.3389/fmicb.2021.815173. eCollection 2021.
6
Structural and Enzymatic Characterization of ABgp46, a Novel Phage Endolysin with Broad Anti-Gram-Negative Bacterial Activity.ABgp46的结构与酶学特性研究，一种具有广泛抗革兰氏阴性菌活性的新型噬菌体溶菌酶
Front Microbiol. 2016 Feb 26;7:208. doi: 10.3389/fmicb.2016.00208. eCollection 2016.
7
Efficacy of bacteriophage treatment against carbapenem-resistant Acinetobacter baumannii in Galleria mellonella larvae and a mouse model of acute pneumonia.噬菌体治疗对粘质沙雷氏菌在金斑蝶幼虫和急性肺炎小鼠模型中的抗药性的疗效。
BMC Microbiol. 2019 Apr 2;19(1):70. doi: 10.1186/s12866-019-1443-5.
8
Enhanced Antibacterial Activity of Acinetobacter baumannii Bacteriophage ØABP-01 Endolysin (LysABP-01) in Combination with Colistin.鲍曼不动杆菌噬菌体ØABP - 01内溶素（LysABP - 01）与黏菌素联合使用时增强的抗菌活性。
Front Microbiol. 2016 Sep 7;7:1402. doi: 10.3389/fmicb.2016.01402. eCollection 2016.
9
Corrigendum: The Capsule Depolymerase Dpo48 Rescues and Mice From Systemic Infections.勘误：胶囊解聚酶Dpo48拯救小鼠免受全身感染。
Front Microbiol. 2019 Apr 30;10:942. doi: 10.3389/fmicb.2019.00942. eCollection 2019.
10
Combined Use of the Ab105-2φΔCI Lytic Mutant Phage and Different Antibiotics in Clinical Isolates of Multi-Resistant .多耐药临床分离株中Ab105 - 2φΔCI裂解突变噬菌体与不同抗生素的联合使用
Microorganisms. 2019 Nov 12;7(11):556. doi: 10.3390/microorganisms7110556.
引用本文的文献
1
Bacteriophages and their derived enzymes as promising alternatives for the treatment of Acinetobacter baumannii infections.噬菌体及其衍生酶作为治疗鲍曼不动杆菌感染的有前途的替代品。
Arch Virol. 2023 Nov 10;168(12):288. doi: 10.1007/s00705-023-05910-7.
Zotero 插件